mid-cap

One NASDAQ-Listed Cannabis Company at Resistance Level: TLRY

Dec 18, 2025 | Team Kalkine

Read Time :10 Mins

One NASDAQ-Listed Cannabis Company at Resistance Level: TLRY — Image source: Shutterstock

TLRY:NASDAQ
Investment Type

Mid - Cap
Risk Level
Action
Rec. Price (US$)

Tilray Brands Inc

Tilray Brands, Inc. (NASDAQ: TLRY) is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business.

As per previous Kalkine’s US Daily Report published on ‘TLRY’ on December 15, 2025, Kalkine provided an ‘Speculative Buy’ stance on the stock at USD 12.15 based on fundamental analysis and the stock price has now moved up by ~19.26% since then, attaining resistance 1 and resistance 2.

Noted below are the details of support and resistance levels provided in our previous report:

Share Price Chart

Considering a volatile market condition led by recent tariffs escalation from United States and subsequent retaliation, resistance 1 and resistance 2 attainment, recessionary fear, higher interest rate and geopolitical disruption, a "Sell" recommendation on Tilray Brands, Inc. (NASDAQ: TLRY) has been given at the current market price of USD 14.49 as on 18 December 2025, at 07:10 am PST.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is 18 December 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’

Note 6: Dividend Yield may vary as per the stock price movement.

Small-Cap

Quantum Corporation: Balance Sheet Improvements Overshadowed by Operational Uncertainty

Jun 22, 2026 Team Kalkine

Mid-Cap

One NYSE-Listed Industrials Company Near Resistance Level: CPA

Jun 22, 2026 Team Kalkine

Small-Cap

Ceres Power’s Licensing Model Under Pressure — What Comes Next?

Jun 22, 2026 Team Kalkine

Small-Cap

Contract Wins Aren't Enough — Can ITM Power Prove Its Business Model?

Jun 22, 2026 Team Kalkine

Mid-Cap

MSB Remains Loss-Making with Continued Negative Cash Flow

Jun 21, 2026 Team Kalkine

Disclaimer-

This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.

Past performance is not a reliable indicator of future performance.